Kanngongkanngoen

Why Is U.S. Health Care So Expensive? Claims and Data to Check

💡 Key takeaways

The clip raises claims about ambulances, administration, drug patents, insurance, debt, and bankruptcy. Official figures show system scale, not proof of each cause.

The clip “Why health care in the US is so unaffordable. Full podcast dropping very soon!” from CK Cheong was published on April 3, 2025. Its title identifies it as a teaser before a full podcast, not a comprehensive analysis of the U.S. health system.

The title says that a full podcast was coming soon. The discussion below summarizes only the points made by the speaker; it is not a complete analysis of the U.S. health system, and the summary has not been checked against the video's audio.

Points raised in the clip

CK Cheong describes growing up in the United States and gives an example involving the cost of an ambulance. He then offers the view that specialization and multiple layers of administration may increase costs, discusses drug patents and incentives for insurance companies, and connects health-care costs with debt and bankruptcy.

These are points and explanations from the speaker in a short clip. They do not prove that these factors are the only or main causes of health costs nationwide. The transcript text does not provide documents or calculation methods for the ambulance-cost example or the bankruptcy claim, so this article does not present those figures or conclusions as general facts.

Checking the statement about drug patents

The transcript says that a patent lasts only 10 years. That is not the general rule for U.S. patents: the USPTO says a utility patent generally lasts 20 years from its filing date, subject to relevant conditions and exceptions. See the USPTO's information on managing patents.

For medicines, patent term is not the same as the period of market exclusivity that the FDA grants to some drugs. The FDA explains that patents and exclusivity are separate rights and may begin or end at different times. An analysis of a specific drug or company must therefore check that drug's patent listings and approval status rather than infer them from this clip. See the FDA's frequently asked questions about patents and exclusivity.

Official figures describe the system's scale, not every cause

The Centers for Medicare & Medicaid Services (CMS) National Health Expenditure Accounts report U.S. health spending of $5.3 trillion in 2024, or

5,474 per person and 18.0% of GDP. These figures show the scale and overall trend of the system; they do not prove that the ambulance, administrative work, patent, or claim-denial explanations in the clip caused the high costs. See CMS historical National Health Expenditure data.

This video should be read as a perspective from a short conversation that needs further checking. This article is not medical, insurance, or legal advice, and it does not claim that the U.S. system works the same way in every location or under every policy.

KGK

Kanngongkanngoen Editorial Team

We create clear educational content about personal finance, investing, and debt management, with an emphasis on accuracy and transparency.